Brain

Genzyme targets BBB

Genzyme targets BBB

By Nick Taylor

Genzyme is evaluating to-BBB’s G-Technology as part of a research collaboration aimed at developing treatments capable of crossing the blood-brain barrier (BBB).

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers